Now, Cannabotech, an Israeli biomedical firm that innovates botanical-based solutions for oncology and preventive medicine, has found promising results in an experiment involving its Integrative-Colon product, based on a press release. The formula combines mushroom extracts together with cannabinoids from the cannabis plant, then tested on various subtypes of colon cancer. They found that the ingredients of the formulation acted more effectively compared to isolating the cannabinoids, and that the active ingredients showed great synergy working together. Based on the findings, the Integrative-Colon product was able to kill more than 90% of colon cancer cells
Cannabis grower and edibles pioneer Maya Elisabeth makes the case that your sourdough starter is…
Berlin police are warning residents after receiving reports that suspected drug samples were being left…
Cannabis culture survived through decentralized human connection. Its future depends on whether the people building…
For years, the cannabis world has treated "the entourage effect" like settled science, a comforting…
After five years, two applications, six figures in expenses, and a maze of shifting rules,…
This article was originally published in 2023. From the hash and honey oil of the…